• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    MICRO Expands with New Facility in Costa Rica

    DiaSorin to Buy Luminex for $1.8B

    Endologix Acquires PQ Bypass

    Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems

    Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    Creganna Medical, part of TE Connectivity

    Spectrum Plastics Group

    Medbio LLC

    Forefront Medical Technology
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing

    Digging into the Cardiac Arrhythmia Monitoring Device Market
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    Medbio LLC

    Creganna Medical, part of TE Connectivity

    maxon

    Trademark Plastics Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA OKs Nightware's Device to Reduce Nightmare-Based Sleep Disturbance

    Device provides gentle vibration through touch based on analysis of heart rate and motion during sleep.

    U.S. Food and Drug Administration11.09.20
    The U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD). The device provides gentle vibration through touch based on an analysis of heart rate and motion during sleep.
     
    “Sleep is an essential part of a person’s daily routine. However, certain adults who have a nightmare disorder or who experience nightmares from PTSD are not able to get the rest they need. Today’s authorization offers a new, low-risk treatment option that uses digital technology in an effort to provide temporary relief from sleep disturbance related to nightmares,” said Carlos Peña, Ph.D., director of the Office of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health.
     
    PTSD is a disorder that develops in some people who have experienced a shocking, scary, or dangerous event. People may experience a range of reactions after trauma, and most will recover from their symptoms over time. Those who continue to experience symptoms, which can include sleep problems and nightmares, may be diagnosed with PTSD. Certain medications may help address specific PTSD symptoms, such as sleep problems and nightmares. An experienced mental health professional can help people find the treatment plan that meets their symptoms and needs.
     
    The device, called Nightware, is a digital therapeutic that uses an Apple Watch and an Apple iPhone that are configured and logged into a software application and the Nightware server. Throughout the night, Apple Watch sensors monitor body movement and heart rate during sleep. These data are sent to the Nightware server and, using a proprietary algorithm, the device creates a unique sleep profile for the patient. When Nightware detects that a patient is experiencing a nightmare based on its analysis of heart rate and body movement, the device provides vibrations through the Apple Watch while the product is in use. Nightware is available by prescription only and is intended for home use.
     
    This device was studied in a 30-day randomized, sham-controlled trial of 70 patients. A sham therapy is an inactive treatment or procedure that is intended to mimic as closely as possible a therapy in a clinical trial. Patients in the sham group wore the device, but no vibratory stimulation was provided. Safety was assessed using validated measurements of suicidality and sleepiness, and there were no changes in either over the course of the study in either group. Sleep was assessed with two versions of the Pittsburgh Sleep Quality Index scale, the self-rated questionnaire for assessing sleep quality, including a version of that scale that is intended for patients with PTSD. Both the sham and active groups showed improvement on the sleep scales, with the active group showing greater improvement than sham. The evidence demonstrated the probable benefits outweighed the probable risks.
     
    Nightware is not a standalone therapy for PTSD. The device should be used in conjunction with prescribed medications for PTSD and other recommended therapies for PTSD-associated nightmares and nightmare disorder, according to relevant consensus guidelines. Nightware is intended to be used under the supervision of a healthcare provider. Patients who have been known to “act out” during their nightmares (sleepwalking, violence) should not use Nightware. A healthcare provider should be contacted if daytime sleepiness occurs (If you feel drowsy, do not drive or operate heavy machinery); if the watch vibration causes awakenings not associated with nightmares; or if nightmares persist, worsen, or recur. The watch included in the Nightware kit should be used every night when the user is planning to go to sleep. The watch should not be worn while reading or watching television in bed as this may trigger false alerts. Users should not wear the watch too tightly. If skin irritation occurs, users should discontinue the use of the watch and contact a healthcare provider. The watch included in the Nightware kit may disturb the sleep of the user’s bedpartner if the bedpartner is in contact with the watch when it vibrates. Patients are advised to avoid letting the watch come in contact with their bedpartner at night.
     
    Nightware was granted Breakthrough Device designation for the treatment of nightmares in patients with PTSD. Breakthrough Device designation is a process designed to expedite the development and review of devices that may provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
     
    The FDA reviewed the device through the De Novo premarket review pathway, a regulatory pathway for low- to moderate-risk devices of a new type. Along with this authorization, the FDA is establishing special controls for devices of this type, including requirements related to labeling and performance testing. When met, the special controls, along with general controls, provide reasonable assurance of safety and effectiveness for devices of this type. This action creates a new regulatory classification, which means that subsequent devices of the same type with the same intended use may go through FDA’s 510(k) premarket process, whereby devices can obtain marketing authorization by demonstrating substantial equivalence to a predicate device. The regulation created is for digital therapy device to reduce sleep disturbance for psychiatric conditions, prescription devices that are intended to provide stimulation using a general purpose computing platform to reduce sleep disturbance in patients who experience this symptom due to psychiatric conditions such as nightmare disorder or PTSD.
     
    The FDA granted the marketing authorization to Nightware Inc.
    Related Searches
    • Patient Monitoring
    • Neurological
    Related Knowledge Center
    • Neurological
    • Patient Monitoring

    Related Breaking News

    • Neurological
      ZOLL Buys Sleep Apnea Device Maker Respicardia

      ZOLL Buys Sleep Apnea Device Maker Respicardia

      Respicardia's remedē system, an implantable neurostimulator, treats central sleep apnea.
      Sam Brusco, Associate Editor 04.12.21

    • Chronic Disease | Digital Health | Patient Monitoring
      Welldoc, Dexcom Expand Strategic Partnership for Diabetes Management

      Welldoc, Dexcom Expand Strategic Partnership for Diabetes Management

      Companies to integrate CGM, lifestyle management platforms to offer integrated type 2 diabetes solution.
      Sam Brusco, Associate Editor 04.05.21

    • Neurological
      Encora

      Encora's Tremor Reducing Wristband Gains Breakthrough Status

      Indicated to provide temporary hand tremor relief in adult essential tremor or Parkinson's patients.
      Sam Brusco, Associate Editor 03.31.21


    • Cardiovascular | Patient Monitoring
      GE Healthcare Reveals Venue Fit POC Ultrasound with Cardiac AI Tool

      GE Healthcare Reveals Venue Fit POC Ultrasound with Cardiac AI Tool

      AI tool continuously calculates the heart’s real-time ejection fraction.
      Sam Brusco, Associate Editor 03.31.21

    • Neurological | Patient Monitoring
      FDA OKs Brain Scientific

      FDA OKs Brain Scientific's Next-Gen NeuroCap EEG Headset

      NeuroCap's advanced EEG electrode array obtains rapid EEGs in routine clinical and research settings.
      Sam Brusco, Associate Editor 03.10.21

    • Neurological
      Medtronic Receives FDA Approval for Expanded MRI Labeling

      Medtronic Receives FDA Approval for Expanded MRI Labeling

      Updated MRI Guidelines allow for a wider range of MRI scan parameters and shorter wait time between MRI scans.
      Charles Sternberg, Assistant Editor 02.18.21


    • Neurological
      FDA OKs electroCore

      FDA OKs electroCore's gammaCore nVNS for Adolescent Migraine

      It’s now cleared for most forms of primary headache.
      Sam Brusco, Associate Editor 02.16.21

    • Neurological
      FDA Approves Axonics

      FDA Approves Axonics' 3rd-Gen Implantable Neurostimulator

      Upgrades its embedded software and the patient remote control’s functionality.
      Sam Brusco, Associate Editor 02.16.21

    • Digital Health | Patient Monitoring
      Masimo Launches Tool to Support Reopening Schools, Businesses

      Masimo Launches Tool to Support Reopening Schools, Businesses

      Masimo SafetyNet-OPEN helps screen, trace, and manage users as they face COVID-19 and other infectious illnesses.
      Sam Brusco, Associate Editor 02.16.21


    • Cardiovascular | Neurological
      Cerus Endovascular

      Cerus Endovascular's Contour Neurovascular System Gains Breakthrough Status

      Indicated for the treatment of intracranial aneurysms.
      Sam Brusco, Associate Editor 02.12.21

    • Digital Health | Patient Monitoring | Software & IT
      FDA OKs CLEW

      FDA OKs CLEW's AI-Based ICU Predictive Analytics Tech

      CLEWICU predicts hemodynamic instability in adult patients.
      Sam Brusco, Associate Editor 02.04.21

    • Digital Health | Patient Monitoring
      Philips Inks Connected Care Solutions Deal with 28-Hospital Dutch SAZ Group

      Philips Inks Connected Care Solutions Deal with 28-Hospital Dutch SAZ Group

      Different SAZ hospitals will start with Philips solutions for patient monitoring and self-management.
      Sam Brusco, Associate Editor 02.04.21


    • Neurological
      Nēsos Earbud Receives Validation for Treatment of Rheumatoid Arthritis

      Nēsos Earbud Receives Validation for Treatment of Rheumatoid Arthritis

      New study shows promising efficacy and safety profile for novel ‘e-mmunotherapy’ approach to disease treatment.
      Charles Sternberg, Assistant Editor 02.02.21

    • Patient Monitoring
      Hillrom Buys EarlySense

      Hillrom Buys EarlySense's Contact-Free Continuous Monitoring Tech

      EarlySense's contact-free continuous monitoring, analytics tech was integrated into the Centrella Smart+ med-surg bed.
      Sam Brusco, Associate Editor 02.01.21

    • Neurological
      Boston Scientific

      Boston Scientific's Vercise Genus DBS Earns FDA Approval

      Fourth-generation DBS portfolio features full-body MR conditional devices.
      Sam Brusco, Associate Editor 01.22.21


    Trending
    • Endologix Acquires PQ Bypass
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • DiaSorin To Buy Luminex For $1.8B
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Avantor To Acquire Ritter GmbH And Affiliates For $1B
    Breaking News
    • MICRO Expands with New Facility in Costa Rica
    • DiaSorin to Buy Luminex for $1.8B
    • Endologix Acquires PQ Bypass
    • Algorithm Can Predict Acute Kidney Injury Sooner Than Hospital Systems
    • Elixir Medical Begins Study of Metallic Implant for CAD Treatment
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    4-week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    Review Covers Role of Vitamin K2 in the ‘Calcium Paradox’
    KD Pharma Acquires Rohner AG Manufacturing Assets
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    Sika Expands Production Capacity in Qatar
    Sto Corp. ISO Certifications Extended
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MICRO Expands with New Facility in Costa Rica
    DiaSorin to Buy Luminex for $1.8B
    Endologix Acquires PQ Bypass
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Catalent Biologics Completes Madison Expansion
    Lonza Expands PyroTec PRO for Endotoxin Testing
    FDA Accepts Airway Therapeutics’ IND for COVID Treatment
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revieve Launches Skin Coach
    Carlyle Group Acquires Majority Stake in Beautycounter
    The Honest Co. Files for an Initial Public Offering
    Happi

    Latest Breaking News From Happi

    Babor Professional Skin Care Names McCaffrey as Vice President of Sales
    Diamond Chemical Appoints Technical Service Representative
    Carlyle To Acquire Majority Stake in Beautycounter
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Enprom helps converter respond to flexible packaging needs
    anytron assists medical device company with labeling
    Dantex debuts new capabilities with white ink opacity
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Aries Face Masks Meet ASTM Standards
    Tufropes Launches Inherently Antibacterial and Antimicrobial Spunbond
    NXTNano Adding Three Lines
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    GreenBone Ortho Closes 10 Million Euros Series B Funding Round
    SynerFuse, Cirtec Medical Partner to Develop Back Pain Management Device
    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    First Solar Series 6 CuRe has Industry’s Lowest Warranted Degradation Rate
    SEMI: 2020 Global Semiconductor Equipment Sales Surge 19% to Industry Record $71.2 Billion

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login